ASK REDCHAT ANYTHING ABOUT CAPRICOR THERAPEUTICS INC.
Capricor Therapeutics Inc. (NASDAQ: CAPR)
Listen to this Section
$26.86
-1.0900
(
-3.90% )
247.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| CAP-1002DetailsCOVID-19 |
Failed |
Market Data
|
| Open |
$26.86 |
| Previous Close |
$27.95 |
| Volume |
247.4K |
| Market Cap |
$1.60B |
| Day Range |
$26.84 - $28.19 |
| 52 Week Range |
$4.30 - $40.37 |
| Shares Outstanding |
57.91M |
| Change % |
-3.90% |
| Net Change |
▼ -1.0900 |
| Insider Ownership |
0.24% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2002 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
1,783,668.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-10-06 |
Buy |
2500.00 |
Musket David B |
| 2023-09-06 |
Sale |
-115000.00 |
Kelliher Mike |
| 2023-08-16 |
Sale |
-20748.00 |
Litvack Frank |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
1 |
Apr 03, 2026 |
| 4 |
Insider transactions |
1 |
Apr 01, 2026 |
| 4 |
Insider transactions |
1 |
Apr 01, 2026 |
| 4 |
Insider transactions |
1 |
Apr 01, 2026 |
| pre |
Proxies and info statements |
19 |
Mar 31, 2026 |
| 4 |
Insider transactions |
1 |
Mar 27, 2026 |
| 10-k |
Annual reports |
91 |
Mar 17, 2026 |
| 8-k |
8K-related |
14 |
Mar 12, 2026 |
| 8-k |
8K-related |
14 |
Mar 10, 2026 |
| schedule |
Other |
3 |
Feb 26, 2026 |